Prevention and prophylaxis of invasive fungal sinusitis in the immunocompromised patient

P N Malani; C A Kauffman

doi:10.1016/s0030-6665(00)80006-7

Prevention and prophylaxis of invasive fungal sinusitis in the immunocompromised patient

Otolaryngol Clin North Am. 2000 Apr;33(2):301-12. doi: 10.1016/s0030-6665(00)80006-7.

Authors

P N Malani¹, C A Kauffman

Affiliation

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

PMID: 10736405
DOI: 10.1016/s0030-6665(00)80006-7

Abstract

Fungal infections are a leading cause of morbidity and mortality among immunocompromised patients. Invasive fungal sinusitis is a devastating complication of immunosuppression. Treatment options are limited and often ineffective, making prevention important. Measures to decrease environmental exposure, indications for antifungal prophylaxis, and limitations of current regimens are discussed.

Publication types

Review

MeSH terms

Antifungal Agents / therapeutic use*
Humans
Immunocompromised Host*
Mycoses*
Paranasal Sinus Diseases* / diagnosis
Paranasal Sinus Diseases* / immunology
Paranasal Sinus Diseases* / microbiology
Paranasal Sinus Diseases* / prevention & control
Risk Factors
Tomography, X-Ray Computed

Substances

Antifungal Agents